NCT06477172 Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
| NCT ID | NCT06477172 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Acorn Biolabs Inc. |
| Condition | Post Procedural Erythema |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-09-09 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-09-09 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.
Eligibility Criteria
Inclusion Criteria: * Male and Female * Ages: 18-60 * Any Fitzpatrick skin type * Planning a medical aesthetic procedure * For subjects receiving hair procedures (closed to enrollment): 1. Androgenic alopecia 2. Traction alopecia 3. Scarring alopecia 4. Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed. 5. No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period. * Undergoing one of the following medical aesthetic procedures: 1. Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face (Ellacor closed to enrollment) 2. Tixel of the face 3. Keralase of the scalp (scalp treatment closed to enrollment) 4. Acne Scars and Surgery scars, either old or new as long as old scars are also being treated with ablative or non-ablative laser or microneedling (e.g. abdominoplasty, breast reduction/ reconstruction/enhancement, post-weight loss, etc. * Planning to use Acorn Autologous Hair Follicle Secretome cosmetic product Exclusion Criteria: * Pregnant or Breastfeeding * Participation in an interventional clinical trial in the last 30 days * Use of other topical cosmetic products that may confound results * Use of retinoids within 7 days prior to facial procedure * For those receiving hair treatment, must not have had a hair transplant in the treatment area within the past 12 months * Any health condition that in the investigator's opinion should preclude participation in study
Contact & Investigator
Drew Taylor, PhD
STUDY CHAIR
Acorn Biolabs
Frequently Asked Questions
Who can join the NCT06477172 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post Procedural Erythema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06477172 currently recruiting?
Yes, NCT06477172 is actively recruiting participants. Contact the research team at lisa.campbell@acorn.me for enrollment information.
Where is the NCT06477172 trial being conducted?
This trial is being conducted at Birmingham, United States, Scottsdale, United States, Beverly Hills, United States, Beverly Hills, United States and 11 additional locations.
Who is sponsoring the NCT06477172 clinical trial?
NCT06477172 is sponsored by Acorn Biolabs Inc.. The principal investigator is Drew Taylor, PhD at Acorn Biolabs. The trial plans to enroll 500 participants.